BioSpace News Archive

BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, announces that further to its news release dated August 11, 2020,

Adds clinically advanced oral BTK inhibitor rilzabrutinib with potential across a range of immunology and inflammation indications, complementing Sanofi’s existing R&D pipeline

Data support potential as novel and differentiated COVID-19 vaccine designed against multiple SARS-CoV-2targets with technology known to induce memory T lymphocytes

Agreement comes as United Arab Emirates (UAE) and Israel Reach Historic Agreement to Fully Normalize Diplomatic Relations

Salman Arif, the CEO of The Health Bank (THB) Global , announced today that the company is partnering with Nanotronics Health, LLC, to distribute nHale TM , a non-invasive ventilator. It will be distributed in the Middle East, North Africa and South Asia (MENASA) region. To support non-invasive respiratory therapy in the region, The Health Bank will also train medical professionals to operate the device.

GNI Group Ltd., a commercial-stage biopharmaceutical company, announced positive results from the initial analysis of Phase II clinical trial of the F351 drug candidate for liver fibrosis.

Priority Review for trilaciclib is based on positive data from three randomized clinical trials showing robust myelopreservation benefits

CARsgen Therapeutics, a leader in developing novel CAR-T cell therapies against solid tumors, announced its publication of the 7×21 CAR-T technology in CLINICAL CANCER RESEARCH.

Seneca Therapeutics, Inc. announced the appointment of James M. Hussey as Chief Executive Officer and member of the Board of Directors.

TOMI Environmental Solutions, Inc. ® (“TOMI”) (OTCQB:TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). Dr. Halden Shane, TOMI’s CEO, states, “There have been many inquiries about our stock price decline despite the company deliv